UPDATE : Monday, April 22, 2019
상단여백
Immunotherapies’ liver cancer-treating effects confirmed in real-world studies
Researchers unveiled the world’s first real-world data to show how immunoth...
by Kim Yun-mi  |  2019-04-15 14:29
라인
All Invossa products contained 293 cells, Kolon confirms
Kolon Life Science said all of the cells used for manufacturing Invossa &nd...
by Jeong Sae-im  |  2019-04-15 11:31
라인
Pharmacists’ group demand legalizing abortion pill Mifegyne
In the wake of the Constitutional Court’s ruling that abortion ban is uncon...
by Song Soo-youn  |  2019-04-12 15:20
라인
‘Embitterment’ draws Korean psychiatrists’ attention
The local psychiatrist community is showing keen attention to embitterment ...
by Song Soo-youn  |  2019-04-12 14:53
라인
Invossa license won’t be revoked: Kolon CEO
Kolon Life Science remained confident that the regulator would not nullify ...
by Jeong Sae-im  |  2019-04-12 11:40
라인
Anti-abortion law ruled unconstitutional in Korea
The Constitutional Court on Thursday ruled that the provisions governing th...
by Choi Gwang-seok  |  2019-04-11 18:02
라인
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests
After the Ministry of Food and Drug Safety announced that it would graduall...
by Lee Hye-seon  |  2019-04-11 16:00
라인
Gil Medical Center exports medical education system to Uzbekistan
Gacheon University Gil Medical Center said Thursday that it would start its...
by Lee Han-soo  |  2019-04-11 16:00
라인
NCC finds clue in developing anticancer drugs without side effects
Researchers from the National Cancer Center (NCC) have discovered the antic...
by Lee Han-soo  |  2019-04-11 14:53
라인
Regulator, Kolon rebuked for slow response to Invossa problem
Late February: Kolon Life Science, Kolon TissueGene recognize mislabeled ce...
by Jeong Sae-im  |  2019-04-11 14:46
라인
Doctors skeptical about GSK’s new HIV drug despite FDA nod
The U.S. Food and Drug Administration recently approved GSK’s combination d...
by Kim Yun-mi  |  2019-04-11 13:55
라인
Canada OKs Celltrion’s Truxima
Celltrion said Thursday that it has received regulatory approval for Truxim...
by Lee Han-soo  |  2019-04-11 11:33
라인
Genematrix’s multi-pathogen diagnostic kit wins European certification
Genematrix announced Thursday that it has acquired the Conformite Europeenn...
by Lee Han-soo  |  2019-04-11 11:33
라인
Hana says US Cosmo submits new drug application for Remimazolam
U.S.-based Cosmo Pharmaceutical has submitted a new drug application (NDA) ...
by Lee Han-soo  |  2019-04-10 17:51
라인
Boryung Bio, CancerRop launch non-invasive prenatal test
Boryung Biopharma said that Monday that it plans to launch the “Mom Scannin...
by Lee Han-soo  |  2019-04-10 16:54
라인
‘Fine dust can increase risk of acute atrial fibrillation’
Researchers at Seoul National University Bundang Hospital have found that f...
by Lee Han-soo  |  2019-04-10 16:53
라인
Regulator to probe Kolon with all possible scenarios over Invossa debacle
The Ministry of Food and Drug Safety said it would investigate the safety i...
by Lee Hye-seon  |  2019-04-10 15:37
라인
Korea to spend ₩480 billion for pharma, biotech sector
The government said it would spend 477.9 billion won ($419.3 million) to he...
by Kwak Sung-sun  |  2019-04-10 15:32
라인
Thailand OKs T&R Biofab 3D printing device
T&R Biofab said Thursday that it has obtained sales approval from the Thail...
by Lee Han-soo  |  2019-04-10 14:50
라인
Patients may file class-action lawsuit against Kolon for mislabeling Invossa
Korean patients, who received Invossa-K injection for degenerative arthriti...
by Jeong Sae-im  |  2019-04-10 14:41
여백
여백
여백
Back to Top